Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. (Q43632894)
Jump to navigation
Jump to search
scientific article published on 4 August 2008
- Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. |
scientific article published on 4 August 2008 |
|
Statements
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study (English)
P J Mease
K Hobbs
A Chalmers
A Bookman
E Keystone
D E Furst
P Anklesaria
4 August 2008